Analysts’ new coverage for Monday, July 13th:
JPMorgan Chase & Co. began coverage on shares of Alkermes (NASDAQ:ALKS). They issued a neutral rating and a $60.00 price target on the stock.
HC Wainwright began coverage on shares of Apyx Medical (NASDAQ:APYX). The firm issued a buy rating and a $7.00 target price on the stock.
Stifel Nicolaus started coverage on shares of Candel Therapeutics (NASDAQ:CADL). Stifel Nicolaus issued a buy rating and a $22.00 price target on the stock.
BWS Financial began coverage on shares of Capstone Energy+ (NASDAQ:CEPL). They issued a buy rating and a $20.00 target price on the stock.
Benchmark Co. started coverage on shares of Walt Disney (NYSE:DIS). The firm issued a buy rating and a $115.00 price target on the stock.
JPMorgan Chase & Co. assumed coverage on shares of Denali Therapeutics (NASDAQ:DNLI). They issued an overweight rating and a $29.00 price target on the stock.
Raymond James Financial, Inc. initiated coverage on shares of First Carolina Financial Services (NYSE:FCBM). They issued an outperform rating and a $15.00 price target on the stock.
Lake Street Capital assumed coverage on shares of Glass House Brands (NYSE:GLAS). They issued a buy rating and a $17.00 target price on the stock.
Evercore Inc began coverage on shares of Honeywell Aerospace (NASDAQ:HONA). The firm issued an in-line rating and a $250.00 price target on the stock.
Leerink Partners began coverage on shares of Kardigan (NASDAQ:KARD). Leerink Partners issued an outperform rating and a $37.00 target price on the stock.
JPMorgan Chase & Co. started coverage on shares of Kardigan (NASDAQ:KARD). They issued an overweight rating and a $51.00 price target on the stock.
JPMorgan Chase & Co. started coverage on shares of Legend Biotech (NASDAQ:LEGN). They issued a neutral rating and a $35.00 target price on the stock.
Tigress Financial began coverage on shares of Liftoff Mobile (NASDAQ:LFTO). They issued a buy rating and a $39.00 price target on the stock.
Laidlaw started coverage on shares of NLS Pharmaceutics (NASDAQ:NCEL). Laidlaw issued a buy rating and a $23.00 price target on the stock.
Leerink Partners assumed coverage on shares of NervGen Pharma (NASDAQ:NGEN). They issued an outperform rating and a $10.00 target price on the stock.
JPMorgan Chase & Co. initiated coverage on shares of NovoCure (NASDAQ:NVCR). JPMorgan Chase & Co. issued a neutral rating and a $17.00 target price on the stock.
Needham & Company LLC initiated coverage on shares of Park Aerospace (NYSE:PKE). They issued a buy rating and a $43.00 target price on the stock.
B. Riley Financial, Inc. began coverage on shares of Spruce Biosciences (NASDAQ:SPRB). They issued a buy rating and a $160.00 price target on the stock.
BNP Paribas Exane initiated coverage on shares of Whirlpool (NYSE:WHR). The firm issued a neutral rating and a $43.00 target price on the stock.
Leerink Partners initiated coverage on shares of Whitehawk Therapeutics (NASDAQ:WHWK). Leerink Partners issued an outperform rating and a $9.00 target price on the stock.
BNP Paribas Exane began coverage on shares of West Pharmaceutical Services (NYSE:WST). They issued an outperform rating and a $447.00 price target on the stock.
Jefferies Financial Group Inc. started coverage on shares of York Space Systems (NYSE:YSS). They issued a buy rating and a $32.00 price target on the stock.
Receive News & Ratings for Alkermes plc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Alkermes plc and related companies with MarketBeat.com's FREE daily email newsletter.
